asn (Total 148 Patents Found)

Asn (148 Patents Found)
La présente invention concerne un procédé pour exploiter une station de base afin de supporter un mode DCR d'un terminal. Le procédé comprend les étapes suivantes, lorsque le terminal est connecté à la station de base : transmettre au terminal un en-tête de supertrame comportant des informations indiquant ...
一种WiMAX网络中ASN中的BSLA定位MS的方法,包括步骤:MS的服务LC通过发送R4信令消息与邻居LC进行协商,以使用所述邻居LC的BSLA进行定位;邻居LC判断服务LC的请求是否可以满足,如果可以满足,则发送R4信令消息表示同意;服务LC进行定位测量,...
In a wireless network 500, a separate layer-three data link 512, 516 is formed between each of a relay station 506, a base station 504 and an access service network gateway (ASN-GW) 502. Each separate layer-three data link 512, 516 is mapped from the ASN-GW 502 to a next element in the wireless network to form a data p...
The present invention is directed to the use of the peptide compound His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, h...
La présente invention concerne l'utilisation du composé peptidique Arg-Asn-I Ie-AIa-Glu-lle-lle-Lys-Asp-lle-OH en tant qu'agent thérapeutique destiné à la prophylaxie et/ou au traitement du cancer, de maladies auto-immunes, de maladies fibreuses, de maladies inflammatoires, de maladies neurodégénérative...
La présente invention concerne un procédé permettant de réaliser des transferts intercellulaires entre des réseaux de services d'accès cibles (ASN), lequel procédé comprend les étapes qui consistent à recevoir, depuis un ASN cible, un message de déclenchement de transfert intercellulaire DPF d'ancrag...
A method for processing handovers between ASNs (Access Service Networks) according to one embodiment of the present invention is capable of processing handovers between ASNs, and includes the steps of receiving, from a target ASN, an anchor DPF handover trigger message containing the information representing the ROHC c...
La présente invention a trait à un processeur de protocole ASN.1, utilisé pour une interaction de protocole entre client et serveur et pour la conversion de données de protocole et de flux d'octets, comportant : un bloc de description de données de protocole présentant un protocole ASN.1 consolidé et un bloc...
La présente invention concerne l'utilisation du composé peptidique His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe en tant qu'agent thérapeutique destiné à la prophylaxie et/ou au traitement du cancer, de maladies auto-immunes, de maladies fibreuses, de maladies inflammatoires, de maladies neurodégén...
La présente invention concerne l'utilisation du composé peptidique Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu-OH en tant qu'agent thérapeutique pour la prophylaxie et/ou le traitement du cancer, de maladies auto-immunes, de maladies fibreuses, de maladies inflammatoires, de maladies neur...
The present invention is directed to the use of the peptide compound His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, h...
본 명세서는 단말의 DCR 모드를 지원하기 위한 기지국의 동작 방법에 있어서, 단말과 연결 모드 상태에서, 상기 기지국이 연결된 네트워크가 레거시 ASN(Legacy Access Service Network)인지를 나타내는 정보를 포함하는 슈퍼 프레임 헤더를 상기 단말로 ...
本发明公开了一种由移动终端主动发起的数据通道建立方法及ASN(接入服务网络),所述ASN中包括:认证授权功能实体(Authenticator)、数据通道功能实体(DPF)及基站(BS);所述方法包括:在由移动终端(MS)主动发起的数据通道建立过程中,当Authenticator...
Subtilisin protease (I) that has, at positions homologous to positions 230, 256 and 259 of subtilisin BPN' from Bacillus amyloliquefaciens, the amino acids (aa) Val, Gly and Asn, respectively, is new. Independent claims are also included for the following: (a) subtilisin proteases (II) that have: (i) at homologo...
Die Erfindung betrifft ein Verfahren zum Umwandeln von Ausgangsdaten (100) in Zieldaten (101) gemäß ASN.1 mit den Schritten eines Einlesens (S102) zumindest einer digitalen Umwandlungsanweisung (103) zum Umwandeln der Ausgangsdaten (100) in einem ersten Datenformat in die Zieldaten (101) in einem zweiten Datenformat ...
A system and method for performing paging in an area where a macro Base Station (BS) and a femto Access Services Network (ASN) are linked in a mobile network are provided. The method includes, during handover of a Mobile Station (MS) between a macro ASN and a femto ASN, a first gateway of a current ASN acquires paging ...
A computer-readable medium is encoded with a method of externalizing legacy data from a legacy database on a data resource into an Extensible Markup Language (“XML”)-compliant format where the format is specified by an automatically generated XML meta-description, thus enabling access and processing of legacy data ...
The present invention is directed to the use of the peptide compound Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu-OH or its combination with the peptide Thr-Thr-Ser-Gln-Val-Arg-Pro-Arg-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, in...
The present invention is directed to the use of the peptide compound Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu-OH or its combination with the peptide Thr-Thr-Ser-Gln-Val-Arg-Pro-Arg-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, in...
This invention is directed to the chemical process for the preparation of the polypeptide, pyroglutamyl-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn and to intermediates in said process. The polypeptide prepared by the present process is useful in the treatment of autoimmune diseases such as Lupus like pathology and specifically fo...
In a data structuring apparatus, input character strings written in accordance with the specification of ISO/8824/ASN.1 are decomposed and keywords representative of types and attributes are detected from the decomposed character strings. Type nodes are created from the detected type representative keywords and attribu...
The present invention discloses an ASN.1 protocol processor for protocol interacting between the server and client and transformation between protocol data and byte stream data, comprising: a protocol data description module in which ASN.1 protocol is integrated and a protocol procedure module in which protocol procedu...
L'invention concerne un procédé de conversion de données de départ (100) en données cibles (101) suivant ASN.1, comprenant une étape de lecture (S102) d'au moins une instruction de conversion numérique (103) servant à convertir les données de départ (100) ayant un premier format de données en donnée...
本发明公开了一种由MS主动发起的数据通道建立方法和ASN系统,所述方法包括:在由所述MS主动发起的数据通道建立过程中,当Authenticator收到携带有成功标识信息的资源预留确认时,如果本地处理异常,则向DPF发起数据通道资源删除请求;当所...
The communication facility (KE) described presents a coupling configuration (ASN) of at least a number N of active power electronics assemblies (BG 1 to BG N), each being connected to at least one transmission line (LTG 1 to LTG N) and forming with an additional standby power electronic assembly (BG N+1) a redundancy g...
本发明涉及一种适用于ASN.1编译器符号表的转换方法,其特点是:构成符号表与构成变量表,且符号表的节点为自定义数据类型,能够表达所有可能的数据类型,其内容至少包括,用于将该节点链接进符号表的双向链表头的hdr参数,用于表达ASN...
一种向用户提供定位业务的方法,包括步骤:LS通过R3接口向位于锚ASN的锚认证实体发送定位请求消息;锚认证实体查询到目标移动台MTMS的状态为ACTIVE后,向LS返回服务LC ID或者服务ASN ID;LS向位于服务ASN的服务LC发送定位请求;服务LC把查到的BS...
1. Комбинация пептидов His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe и Gly-Arg-Gly-Asp-Asn-Pro-OH или их солей или гидратов. ! 4. Комбинация по п.2, где пептиды содержатся в комбинации в количестве от 30% по мас...
Peptides whose structures resemble those of vasopressin antagonists but have both a carboxamido amino acid unit and a basic amino acid unit in the side chain have good antagonist activity. A species of the invention is [1-(β-mercapto-β,β-cyclopentamethylenepropionic acid)-2-(O-ethyl)-D-tyrosine-4-valine-8-glutamine-...